Related Experiment Video
Updated: Feb 7, 2026

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
Streptococcus Agalactiae Infective Endocarditis in a Healthy Middle-aged Man: Uncommon but Life-threatening
Lina Ya'qoub1, Lyna Rehan2, Shailja Parikh3
1Internal Medicine, University of Missouri - Kansas City.
Abstract:
Streptococcus agalactiae (S.agalactiae) is known to cause invasive infections in pregnant women, newborns, and immunosuppressed patients. It is an uncommon but life-threatening case of infective endocarditis in middle-aged otherwise healthy adults. We present a case of a patient with life-threatening infective endocaritis caused by Streptococcus agalactiae, who passed away despite medical treatment.
Insights
Streptococcus agalactiae (S. agalactiae) can cause severe infective endocarditis, even in healthy adults. This case highlights the aggressive nature of S. agalactiae endocarditis, which proved fatal despite treatment.
Area of Science:
- Cardiology
- Infectious Diseases
- Microbiology
Background:
- Streptococcus agalactiae (S. agalactiae) is a significant pathogen, primarily causing invasive infections in vulnerable populations like neonates and pregnant women.
- Infective endocarditis due to S. agalactiae is rare but carries a high mortality risk, particularly in otherwise healthy middle-aged adults.
Observation:
- A case of a middle-aged, healthy adult patient who developed life-threatening infective endocarditis caused by S. agalactiae is presented.
- The patient's condition rapidly deteriorated, underscoring the aggressive potential of this pathogen in endocardial infections.
Findings:
- Despite prompt medical intervention and treatment, the patient succumbed to the severe S. agalactiae infective endocarditis.
- This case illustrates the challenges in managing S. agalactiae endocarditis, even with aggressive therapeutic strategies.
Implications:
- Reinforces the need for heightened clinical suspicion for S. agalactiae in cases of infective endocarditis, irrespective of traditional risk factors.
- Suggests that current treatment protocols may be insufficient for fulminant S. agalactiae endocarditis, necessitating further research into novel therapeutic approaches.
- Emphasizes the critical importance of early diagnosis and aggressive management in improving outcomes for S. agalactiae endocarditis.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
11:16Non-invasive Imaging of the Innate Immune Response in a Zebrafish Larval Model of Streptococcus iniae Infection
Published on: April 21, 2015
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Half-life of a Reaction
Endocarditis I: Introduction
Characteristics of Life
The Angiosperm Life Cycle
Retrovirus Life Cycles